Junyi Wu

1.6k total citations
56 papers, 1.1k citations indexed

About

Junyi Wu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Junyi Wu has authored 56 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Oncology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Junyi Wu's work include Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers) and Renal cell carcinoma treatment (5 papers). Junyi Wu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers) and Renal cell carcinoma treatment (5 papers). Junyi Wu collaborates with scholars based in China, Taiwan and United States. Junyi Wu's co-authors include Junhua Wu, Chunping Jiang, Zhen Qu, Anlai Ji, Yitao Ding, Dongjun Luo, Zhi Ting Ye, Shifen Xu, Ping Yin and Gerhard Litscher and has published in prestigious journals such as PLoS ONE, Advanced Functional Materials and Cancer Research.

In The Last Decade

Junyi Wu

51 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junyi Wu China 16 519 320 129 115 103 56 1.1k
Wenyi Chen China 16 428 0.8× 227 0.7× 91 0.7× 71 0.6× 69 0.7× 50 933
Xinlu Wang China 18 293 0.6× 139 0.4× 87 0.7× 62 0.5× 230 2.2× 102 1.1k
Yu‐Hee Kim South Korea 20 400 0.8× 122 0.4× 111 0.9× 58 0.5× 127 1.2× 52 1.2k
Yoon Shin Park South Korea 22 569 1.1× 130 0.4× 185 1.4× 42 0.4× 126 1.2× 65 1.3k
Jing Liang China 16 207 0.4× 93 0.3× 134 1.0× 51 0.4× 115 1.1× 74 967
Yaohui Wang China 21 359 0.7× 272 0.8× 130 1.0× 48 0.4× 333 3.2× 89 1.5k
Guansong Wang China 28 1.4k 2.7× 246 0.8× 224 1.7× 30 0.3× 125 1.2× 109 2.2k
Lingyun Sun China 25 447 0.9× 89 0.3× 211 1.6× 43 0.4× 110 1.1× 96 1.8k
Hanyuan Liu China 18 416 0.8× 287 0.9× 82 0.6× 36 0.3× 188 1.8× 59 935

Countries citing papers authored by Junyi Wu

Since Specialization
Citations

This map shows the geographic impact of Junyi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyi Wu more than expected).

Fields of papers citing papers by Junyi Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junyi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyi Wu. The network helps show where Junyi Wu may publish in the future.

Co-authorship network of co-authors of Junyi Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Junyi Wu. A scholar is included among the top collaborators of Junyi Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junyi Wu. Junyi Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ye, Shasha, Jingjing Lin, Yujie Zhang, et al.. (2025). RhFGF21 protects the skin from UVB irradiation in diabetic mice through the inhibition of epidermal cell apoptosis and macrophage-mediated inflammation via the SIRT1 signaling pathway. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(4). 167724–167724.
2.
Wu, Jiayi, Junyi Wu, Zhibo Zhang, et al.. (2024). Prognostic Value of Pathological Response for Patients with Unresectable Hepatocellular Carcinoma Undergoing Conversion Surgery. Liver Cancer. 13(5). 498–508. 7 indexed citations
3.
Wu, Junyi, et al.. (2024). Intelligent salivary biosensors for periodontitis: in vitro simulation of oral oxidative stress conditions. Medical & Biological Engineering & Computing. 62(8). 2409–2434. 7 indexed citations
4.
Wu, Junyi, Zhibo Zhang, Shuangjia Wang, et al.. (2024). Impact of Duration of Adjuvant Therapy on Patients with Initially Unresectable Hepatocellular Carcinoma After Conversion Surgery: A Propensity Score Matching Study. Journal of Hepatocellular Carcinoma. Volume 11. 1777–1787.
7.
Wu, Jiayi, Junyi Wu, Yinan Li, et al.. (2023). The TAE score predicts prognosis of unresectable HCC patients treated with TACE plus lenvatinib with PD-1 inhibitors. Hepatology International. 18(2). 651–660. 10 indexed citations
8.
Wang, Jiajun, Wenting Zhang, Li Zhang, et al.. (2023). Elevated Interleukin-37 Associated with Dengue Viral Load in Patients with Dengue Fever. Current Microbiology. 80(5). 171–171. 2 indexed citations
9.
Yang, Lin, Junyi Wu, Yaya Wang, et al.. (2022). Regeneration of duckweed (Lemna turonifera) involves genetic molecular regulation and cyclohexane release. PLoS ONE. 17(1). e0254265–e0254265. 3 indexed citations
11.
Ling, Suk, Junyi Wu, Ruth Chan, et al.. (2021). Peripheral Blood T Cell Gene Expression Responses to Exercise and HMB in Sarcopenia. Nutrients. 13(7). 2313–2313. 14 indexed citations
12.
Chen, Weibo, Junyi Wu, Weiwei Shi, et al.. (2021). PRRX1 deficiency induces mesenchymal‐epithelial transition through PITX2/miR‐200–dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma. Cancer Science. 112(6). 2158–2172. 10 indexed citations
13.
14.
Huang, Xiao‐Xiao, Jiayi Wu, Yannan Bai, et al.. (2021). Outcomes of laparoscopic bile duct exploration for choledocholithiasis with small common bile duct. World Journal of Clinical Cases. 9(8). 1803–1813. 5 indexed citations
15.
Wu, Junyi, et al.. (2020). Cerebral Ischemia-Reperfusion Injury: Lysophosphatidic Acid Mediates Inflammation by Decreasing the Expression of Liver X Receptor. Journal of Molecular Neuroscience. 70(9). 1376–1384. 6 indexed citations
16.
Zhang, Guang, Zhong‐Xia Wang, Weibo Chen, et al.. (2019). Dual effects of gossypol on human hepatocellular carcinoma via endoplasmic reticulum stress and autophagy. The International Journal of Biochemistry & Cell Biology. 113. 48–57. 7 indexed citations
18.
Yao, Yangyang, Lu‐Lu Lin, Hui-Yun Gu, et al.. (2019). Are Corticosteroids Beneficial for Sepsis and Septic Shock? Based on Pooling Analysis of 16 Studies. Frontiers in Pharmacology. 10. 714–714. 12 indexed citations
19.
Wu, Junyi, Anlai Ji, Zhong‐Xia Wang, et al.. (2018). Exosome-Mimetic Nanovesicles from Hepatocytes promote hepatocyte proliferation in vitro and liver regeneration in vivo. Scientific Reports. 8(1). 2471–2471. 86 indexed citations
20.
Sun, Hongcheng, Mujian Teng, Jie Liu, et al.. (2011). FOXM1 expression predicts the prognosis in hepatocellular carcinoma patients after orthotopic liver transplantation combined with the Milan criteria. Cancer Letters. 306(2). 214–222. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026